PTRS

Q: What is the price of Partners Bancorp (PTRS) today?

The price of Partners Bancorp (PTRS) today is $ 0.00, with return of 0% compared to the last year. The price of Partners Bancorp (PTRS) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Partners Bancorp (PTRS) and international markets.

Q: When does Partners Bancorp (PTRS) pay dividends?

Partners Bancorp (PTRS) did not distribute dividends in the last year.

Q: Is Partners Bancorp (PTRS) worth it?

Currently, Partners Bancorp (PTRS) is priced at $ 0.00, with a P/E of 8.12%, representing a deviation of 1,405% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 2.32%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Partners Bancorp (PTRS) stock?

Investing in stocks of Partners Bancorp (PTRS) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Partners Bancorp (PTRS) yield today?

The yield of Partners Bancorp (PTRS) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 2.32%.If you wanted to buy 100 stocks of Partners Bancorp (PTRS) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Partners Bancorp

This asset is no longer available for investment.

View all assets

Price

$ -

return (12m)

0.00%

p/e

8.12

p/bv

0.90

DIVIDEND YIELD

2.32%

price PTRS

PTRS

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of PTRS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals PTRS

review the fundamentals of Partners Bancorp shares

P/E

8.12

Sector: -3.62 Industry: -3.62

P/SALES RATIO (PSR)

1.94

Sector: -3.30 Industry: -3.30

P/BV

0.90

Sector: 2.05 Industry: 2.05

DIVIDEND YIELD (DY)

2.32%

Sector: - Industry: -

ROA

1.03%

Sector: -63.21% Industry: -63.21%

ROE

11.07%

Sector: -66.02% Industry: -66.02%

ROIC

Sector: -1,132.68% Industry: -1,132.68%

NET MARGIN

23.92%

Sector: -41.11% Industry: -41.11%

GROSS MARGIN

73.53%

Sector: 39.13% Industry: 39.13%

OPERATING MARGIN

27.77%

Sector: -40.99% Industry: -40.99%

P/EBITDA

4.97

Sector: -3.65 Industry: -3.65

P/EBIT

4.97

Sector: -3.76 Industry: -3.76

P/ASSET

0.08

Sector: 1.47 Industry: 1.47

BVPS

7.95

Sector: 1.76 Industry: 1.76

EPS

0.88

Sector: -2.04 Industry: -2.04

EQUITY RATIO

0.09

Sector: 0.41 Industry: 0.41

CAGR REVENUE 5 YEARS

4.82%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

22.83%

Sector: - Industry: -

FAIR VALUE OF Partners Bancorp ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 0.00

Fair Value

$ 0.00

Upside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals PTRS

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	19.71	0.00	0.00%	2.47%	$ 495.09 B	27.26%
PFE	14.63	1.54	10.56%	8.46%	$ 143.80 B	15.65%
ABBV	168.68	-154.98	-91.88%	2.88%	$ 402.80 B	4.00%
NVO	14.23	8.21	57.70%	3.42%	$ 219.31 B	32.78%
MRK	13.76	0.00	0.00%	3.09%	$ 261.87 B	29.63%
AZN	30.60	6.26	20.45%	1.69%	$ 287.62 B	16.17%
BMY	16.59	5.39	32.47%	5.04%	$ 100.17 B	12.57%
GILD	19.29	7.29	37.80%	2.50%	$ 156.42 B	27.88%
ZTS	21.42	10.52	49.11%	1.51%	$ 56.78 B	28.21%
HALO	14.03	16.58	118.17%	0.00%	$ 8.35 B	47.91%
REGN	17.72	2.62	14.79%	0.34%	$ 81.14 B	32.13%
AMGN	26.53	19.32	72.82%	2.72%	$ 185.86 B	19.47%
VRTX	30.20	6.41	21.22%	0.00%	$ 111.00 B	31.35%
MCK	27.09	-189.03	-697.75%	0.33%	$ 109.26 B	1.04%
ADMA	21.89	10.63	48.57%	0.00%	$ 4.58 B	42.87%
CAH	31.67	-18.50	-58.40%	0.96%	$ 50.52 B	0.68%
BIIB	16.64	1.47	8.83%	0.00%	$ 26.77 B	15.98%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

PTRS Historical Dividends

current DY: 2.32%

5-year average DY: 1.63%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	11/20/2023	11/27/2023	0,08600000
Dividend	08/10/2023	08/17/2023	0,04000000
Dividend	05/10/2023	05/17/2023	0,04000000
Dividend	02/08/2023	02/15/2023	0,04000000
Dividend	11/09/2022	11/17/2022	0,04000000
Dividend	08/10/2022	08/19/2022	0,02500000
Dividend	05/11/2022	05/16/2022	0,02500000
Dividend	02/08/2022	02/15/2022	0,02500000
Dividend	12/22/2021	12/30/2021	0,02500000
Dividend	09/24/2021	10/01/2021	0,02500000
Dividend	06/24/2021	07/01/2021	0,02500000
Dividend	03/24/2021	04/01/2021	0,02500000
Dividend	12/24/2020	01/02/2021	0,02500000
Dividend	09/28/2020	10/05/2020	0,02500000
Dividend	06/26/2020	07/03/2020	0,02500000

ABOUT THE COMPANY Partners Bancorp

Partners Bancorp

Average user rating I10

4.0 (2 people)

United States

37 years

Founded: 1988

2020

Time since IPO - 5 years

220

Employees

The Company Partners Bancorp (United States), is listed on Nasdaq with a market cap of $ 128.77 Millions, having an equity of $ 143.14 Millions.

With a total of 220 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 66.26 Millions, which generated a profit in the amount of $ 15.85 Millions.

As for its main indicators, the Company has a P/E ratio of 8.12, a P/BV ratio of 0.90 and in the last 12 months the dividend yield of PTRS was at 2.32%.

The Company is traded internationally through the ticker PTRS.

Market cap

$ 128.77 Millions

Equity

$ 143.14 Millions

US$ 143,143,635.00

Assets

$ 1.53 Billion

US$ 1,533,033,525.00

Total Shares Outstanding

18.01 Millions

18,009,000

Average Daily Trading Volume

$ -

US$ -

Sector

Health Care

Industry

Biotechnology

PTRS

PTRS revenue and profits

Financial Results PTRS

DRAG THE FRAME TO SEE MORE DATA

PTRS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 808.62 34,70% (12M)

P/E

27.09

0.33%

ROE

-697.75%

P/BV

-189.03

CAH - Cardinal Health

$ 198.83 64,69% (12M)

P/E

31.67

0.96%

ROE

-58.40%

P/BV

-18.50

JNJ - Johnson & Johnson

$ 201.93 40,51% (12M)

P/E

19.71

2.47%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 99.72 1,13% (12M)

P/E

13.76

3.09%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 26.03 6,95% (12M)

P/E

14.63

8.46%

ROE

10.56%

P/BV

1.54

ABBV - AbbVie

$ 226.08 33,82% (12M)

P/E

168.68

2.88%

ROE

-91.88%

P/BV

-154.98

AZN - AstraZeneca

$ 90.18 35,05% (12M)

P/E

30.60

1.69%

ROE

20.45%

P/BV

6.26

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 808.62 34,70% (12 M)

P/L

27.09

0.33%

ROE

-697.75%

P/VP

-189.03

CAH - Cardinal Health

$ 198.83 64,69% (12 M)

P/L

31.67

0.96%

ROE

-58.40%

P/VP

-18.50

JNJ - Johnson & Johnson

$ 201.93 40,51% (12 M)

P/L

19.71

2.47%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 99.72 1,13% (12 M)

P/L

13.76

3.09%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 26.03 6,95% (12 M)

P/L

14.63

8.46%

ROE

10.56%

P/VP

1.54

ABBV - AbbVie

$ 226.08 33,82% (12 M)

P/L

168.68

2.88%

ROE

-91.88%

P/VP

-154.98

AZN - AstraZeneca

$ 90.18 35,05% (12 M)

P/L

30.60

1.69%

ROE

20.45%

P/VP

6.26

Frequently Asked Questions

What is the price of Partners Bancorp (PTRS) today?

The price of Partners Bancorp (PTRS) today is $ 0.00, with return of 0% compared to the last year. The price of Partners Bancorp (PTRS) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Partners Bancorp (PTRS) and international markets.

When does Partners Bancorp (PTRS) pay dividends?

Partners Bancorp (PTRS) did not distribute dividends in the last year.

Is Partners Bancorp (PTRS) worth it?

Currently, Partners Bancorp (PTRS) is priced at $ 0.00, with a P/E of 8.12%, representing a deviation of 1,405% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 2.32%. The total shareholder return was 0.00%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Partners Bancorp (PTRS) stock?

Investing in stocks of Partners Bancorp (PTRS) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Partners Bancorp (PTRS) yield today?

The yield of Partners Bancorp (PTRS) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 2.32%.

If you wanted to buy 100 stocks of Partners Bancorp (PTRS) today, the total investment would be $ 0.00, based on the current price of $ 0.00.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 0.00
In 5 years: $ 0.00
In 10 years: $ 0.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

PTRS

Partners Bancorp

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of PTRS

review the fundamentals of Partners Bancorp shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 2.32%

5-year average DY: 1.63%

type

Ex - Dividend Date

payment date

value

ABOUT THE COMPANY Partners Bancorp

Partners Bancorp

United States

37 years

2020

220

PROFIT X PRICE PTRS

Financial Results PTRS

PTRS cash flow

asset growth - PTRS

PTRS balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions